IndraLab

Statements



reach
"Although Tozasertib inhibits RIPK1 dependent apoptosis in MEF cells, its inhibition on RIPK1 dependent necroptosis in the same cells is remarkably less effective."

reach
"Overall, these data indicate that the inhibition of Aurora kinases and RIPK1 by Tozasertib and its analogues is correlated to the proliferation and cytokinesis defects and necroptosis protection, respectively."

reach
"Finally, Tozasertib also blocks RIPK1 dependent necroptosis in the human HT29 cell line with an IC50 of 0.26 microM."

No evidence text available

sparser
"Finally, Tozasertib inhibited recombinant human RIPK1, human Aurora A and human Aurora B kinase activity, but not RIPK3."

No evidence text available

sparser
"Overall, these data indicate that the inhibition of Aurora kinases and RIPK1 by Tozasertib and its analogues is correlated to the proliferation and cytokinesis defects and necroptosis protection, respectively."

reach
"Finally, Tozasertib inhibited recombinant human RIPK1, human Aurora A and human Aurora B kinase activity, but not RIPK3."

No evidence text available